Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations.

Cerebral ischemia, as an ischemic stroke-like disease, has become a health problem of global concern. Studies have found that oxidative stress, inflammation, apoptosis, and impaired blood-brain barrier (BBB) and ion channel regulation are the basis for the development of cerebral ischemia pathology. Quercetin, a flavonoid compound, commonly found in the daily diet and in some Chinese herbal medicines, including vegetables, fruits, and tea, is one of the most prominent dietary antioxidants. Modern pharmacological studies have shown that quercetin can effectively protect against cerebral ischemic injury, and its mechanisms may involve antioxidant, anti-inflammatory, anti-apoptotic, BBB protection, ion channel regulation, cell excitatory glutamate toxicity alleviation and cognitive impairment recovery activities. However, the low bioavailability of quercetin and the presence of the BBB structure limit the therapeutic efficacy. There have been studies targeting the delivery of quercetin to the injury site through nanotechnology to enhance the therapeutic effect of quercetin. This review discusses and reviews the pharmacological activity, pharmacokinetic characteristics, and targeted delivery nanosystems of quercetin in protecting against cerebral ischemic injury, and provides information on various downstream signaling pathways regulated by quercetin, such as PI3k/Akt, MAPK, and Sirt1. We hope to provide a scientific basis for the development and application of quercetin in the field of cerebral ischemia.

[1]  Katsuhiko Suzuki,et al.  Dietary Supplementation for Attenuating Exercise-Induced Muscle Damage and Delayed-Onset Muscle Soreness in Humans , 2021, Nutrients.

[2]  Jia-Yu Ke,et al.  The Protective Effect of Quercetin on Endothelial Cells Injured by Hypoxia and Reoxygenation , 2021, Frontiers in Pharmacology.

[3]  Ming-cheng Lin,et al.  Neuroprotective Effect of Quercetin during Cerebral Ischemic Injury Involves Regulation of Essential Elements, Transition Metals, Cu/Zn Ratio, and Antioxidant Activity , 2021, Molecules.

[4]  E. Ioannou,et al.  Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation. , 2021, International journal of pharmaceutics.

[5]  A. Szewczyk,et al.  Cytoprotective effects of the flavonoid quercetin by activating mitochondrial BKCa channels in endothelial cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Yang Ma,et al.  Network pharmacology-based prediction of the active compounds and mechanism of Buyang Huanwu Decoction for ischemic stroke , 2021, Experimental and therapeutic medicine.

[7]  G. Du,et al.  Quercetin attenuates ischemia reperfusion injury by protecting the blood-brain barrier through Sirt1 in MCAO rats , 2021, Journal of Asian natural products research.

[8]  Liang Zhao,et al.  Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons , 2021, Journal of Nanobiotechnology.

[9]  P. Koh,et al.  Quercetin attenuates the reduction of parvalbumin in middle cerebral artery occlusion animal model , 2021, Laboratory animal research.

[10]  Li Duan,et al.  Engineering exosomes for targeted drug delivery , 2021, Theranostics.

[11]  F. D. Ceylan,et al.  Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity , 2020, Journal of agricultural and food chemistry.

[12]  Diji Kuriakose,et al.  Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives , 2020, International journal of molecular sciences.

[13]  J. Plavec,et al.  Preparation and biophysical characterization of Quercetin inclusion complexes with β-cyclodextrin derivatives for the preparation of possible nose-to-brain Quercetin delivery systems. , 2020, Molecular pharmaceutics.

[14]  Jun Zhang,et al.  Quercetin alleviates neonatal hypoxic-ischemic brain injury by inhibiting microglia-derived oxidative stress and TLR4-mediated inflammation , 2020, Inflammation Research.

[15]  Yuan-yuan Zhang,et al.  Protective effect of quercetin against myocardial ischemia as a Ca2+ channel inhibitor: involvement of inhibiting contractility and Ca2+ influx via L-type Ca2+ channels , 2020, Archives of Pharmacal Research.

[16]  Yvonne Perrie,et al.  Liposomes: Advancements and innovation in the manufacturing process. , 2020, Advanced drug delivery reviews.

[17]  Shih-Yi Lin,et al.  Quercetin protects against cerebral ischemia/reperfusion and oxygen glucose deprivation/reoxygenation neurotoxicity. , 2020, The Journal of nutritional biochemistry.

[18]  V. Singh,et al.  Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation , 2020, Inflammation.

[19]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[20]  P. Koh,et al.  Quercetin Reduces Ischemic Brain Injury by Preventing Ischemia-induced Decreases in the Neuronal Calcium Sensor Protein Hippocalcin , 2020, Neuroscience.

[21]  Yan Xiang,et al.  Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration , 2020, Brain Research.

[22]  P. Koh,et al.  Quercetin Attenuates Decrease of Thioredoxin Expression Following Focal Cerebral Ischemia and Glutamate-induced Neuronal Cell Damage , 2019, Neuroscience.

[23]  H. Cui,et al.  Testosterone propionate activated the Nrf2-ARE pathway in ageing rats and ameliorated the age-related changes in liver , 2019, Scientific Reports.

[24]  V. M. Chandrashekhar,et al.  Neuroprotective effect of Convolvulus pluricaulis Choisy in oxidative stress model of cerebral ischaemia reperfusion injury and assessment of MAP2 in rats. , 2019, Journal of ethnopharmacology.

[25]  J. Bhanu,et al.  Role of quercetin and caloric restriction on the biomolecular composition of aged rat cerebral cortex: An FTIR study. , 2019, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[26]  Q. Guo,et al.  Quercetin attenuates hypoxia-ischemia induced brain injury in neonatal rats by inhibiting TLR4/NF-κB signaling pathway. , 2019, International immunopharmacology.

[27]  Zhenzhou Jiang,et al.  Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice , 2019, Phytotherapy research : PTR.

[28]  B. Gaire,et al.  S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK , 2019, Scientific Reports.

[29]  Weibiao Zhou,et al.  In vitro bioaccessibility and bioavailability of quercetin from the quercetin-fortified bread products with reduced glycemic potential. , 2019, Food chemistry.

[30]  P. Koh,et al.  Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells , 2019, The Journal of veterinary medical science.

[31]  G. L. Viswanatha,et al.  Achyranthes aspera Linn. alleviates cerebral ischemia-reperfusion-induced neurocognitive, biochemical, morphological and histological alterations in Wistar rats. , 2019, Journal of ethnopharmacology.

[32]  B. Liu,et al.  Molecular pharmacology of inflammation: Medicinal plants as anti‐inflammatory agents , 2019, Pharmacological research.

[33]  Yun-Cheng Wu,et al.  The Role of Sirt1 in Ischemic Stroke: Pathogenesis and Therapeutic Strategies , 2018, Front. Neurosci..

[34]  Shi-feng Chu,et al.  Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway , 2018, Acta Pharmacologica Sinica.

[35]  P. Ronaldson,et al.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. , 2018, American journal of physiology. Cell physiology.

[36]  B. Gaire Herbal Medicine in Ischemic Stroke: Challenges and Prospective , 2018, Chinese Journal of Integrative Medicine.

[37]  Min Yan,et al.  Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway. , 2018, Chemico-biological interactions.

[38]  P. Koh,et al.  Quercetin attenuates neuronal cells damage in a middle cerebral artery occlusion animal model , 2018, The Journal of veterinary medical science.

[39]  W. Hsu,et al.  Mechanism of intranasal drug delivery directly to the brain , 2018, Life sciences.

[40]  M. Bennett,et al.  Blood-brain barrier dysfunction and recovery after ischemic stroke , 2017, Progress in Neurobiology.

[41]  M. Khazaei,et al.  Oxidative Stress and Cancer: The Role of Nrf2. , 2017, Current cancer drug targets.

[42]  Song Fan,et al.  Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. , 2018, Biomaterials.

[43]  M. Kim,et al.  Quercetin attenuates the injury-induced reduction of γ-enolase expression in a middle cerebral artery occlusion animal model , 2017, Laboratory animal research.

[44]  S. T. Choudhury,et al.  Triphenyl phosphonium coated nano-quercetin for oral delivery: Neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[45]  Ying-zheng Zhao,et al.  Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy. , 2017, International journal of pharmaceutics.

[46]  T. Arumugam,et al.  Emerging Roles of Sirtuins in Ischemic Stroke , 2017, Translational Stroke Research.

[47]  J. Park,et al.  Pretreated quercetin protects gerbil hippocampal CA1 pyramidal neurons from transient cerebral ischemic injury by increasing the expression of antioxidant enzymes , 2017, Neural regeneration research.

[48]  N. Giribabu,et al.  Quercetin ameliorates oxidative stress, inflammation and apoptosis in the heart of streptozotocin-nicotinamide-induced adult male diabetic rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  M. Chao,et al.  Causation by Diesel Exhaust Particles of Endothelial Dysfunctions in Cytotoxicity, Pro-inflammation, Permeability, and Apoptosis Induced by ROS Generation , 2016, Cardiovascular Toxicology.

[50]  Qian Ding,et al.  Remote Limb Ischemic Preconditioning Protects Rats Against Cerebral Ischemia via HIF-1α/AMPK/HSP70 Pathway , 2017, Cellular and Molecular Neurobiology.

[51]  Lian‐Wen Qi,et al.  Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS , 2016, Scientific Reports.

[52]  Bing Pei,et al.  Quercetin ameliorates ischemia/reperfusion-induced cognitive deficits by inhibiting ASK1/JNK3/caspase-3 by enhancing the Akt signaling pathway. , 2016, Biochemical and biophysical research communications.

[53]  Swet Chand Shukla,et al.  A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study , 2016, Neural regeneration research.

[54]  J. Hallenbeck,et al.  Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose , 2016, Journal of neurochemistry.

[55]  Subramani Parasuraman,et al.  Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.

[56]  J. Mlček,et al.  Quercetin and Its Anti-Allergic Immune Response , 2016, Molecules.

[57]  Cory B. Giles,et al.  Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors , 2016, Aging cell.

[58]  Yulong Yin,et al.  Quercetin, Inflammation and Immunity , 2016, Nutrients.

[59]  Fang Yao,et al.  Anti-inflammatory Effect of Mesenchymal Stromal Cell Transplantation and Quercetin Treatment in a Rat Model of Experimental Cerebral Ischemia , 2016, Cellular and Molecular Neurobiology.

[60]  M. Bharath,et al.  Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases , 2015, Neurochemistry International.

[61]  Zong-fang Li,et al.  Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway. , 2015, Molecular medicine reports.

[62]  Seo Yun Jung,et al.  Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects. , 2015, Bioorganic & medicinal chemistry.

[63]  Yiming Li,et al.  Extract of okra lowers blood glucose and serum lipids in high-fat diet-induced obese C57BL/6 mice. , 2014, The Journal of nutritional biochemistry.

[64]  U. Kukongviriyapan,et al.  Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling Pathway , 2014, Phytotherapy research : PTR.

[65]  S. Moon,et al.  Scutellaria baicalensis in stroke management: Nature’s blessing in traditional Eastern medicine , 2014, Chinese Journal of Integrative Medicine.

[66]  Xuebin Qu,et al.  Quercetin improves hypoxia-ischemia induced cognitive deficits via promoting remyelination in neonatal rat , 2014, Brain Research.

[67]  Caiping Wang,et al.  Isoquercetin protects cortical neurons from oxygen–glucose deprivation–reperfusion induced injury via suppression of TLR4–NF-кB signal pathway , 2013, Neurochemistry International.

[68]  Stefan Liebner,et al.  Wnt signaling in the vasculature. , 2013, Experimental cell research.

[69]  Ardhendu Mandal,et al.  Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged Rats , 2013, PloS one.

[70]  A. Holmgren,et al.  Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation. , 2013, Antioxidants & redox signaling.

[71]  Xiong Cao,et al.  An L-Type Calcium Channel Agonist, Bay K8644, Extends the Window of Intervention Against Ischemic Neuronal Injury , 2013, Molecular Neurobiology.

[72]  A. Holmgren,et al.  Thioredoxin system in cell death progression. , 2012, Antioxidants & redox signaling.

[73]  Dashi Qi,et al.  Quercetin Attenuates Cell Apoptosis in Focal Cerebral Ischemia Rat Brain Via Activation of BDNF–TrkB–PI3K/Akt Signaling Pathway , 2012, Neurochemical Research.

[74]  Fang Wang,et al.  Hyperoside protects cortical neurons from oxygen–glucose deprivation–reperfusion induced injury via nitric oxide signal pathway , 2012, Brain Research.

[75]  T. Ishrat,et al.  Quercetin Protects Against Oxidative Stress Associated Damages in a Rat Model of Transient Focal Cerebral Ischemia and Reperfusion , 2011, Neurochemical Research.

[76]  S. Ghosh,et al.  NF-κB in immunobiology , 2011, Cell Research.

[77]  Jean-Christophe Olivier,et al.  Drug transport to brain with targeted nanoparticles , 2011, NeuroRX.

[78]  Hyung-Seok Kim,et al.  Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats , 2011, Acta Neurochirurgica.

[79]  Soohyun Kim,et al.  Chungsim-Yeunja-Tang decreases the inflammatory response in peripheral blood mononuclear cells from patients with cerebral infarction through an NF-κB dependent mechanism , 2010, Journal of Neuroinflammation.

[80]  Charalambos Kaittanis,et al.  Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. , 2010, ACS nano.

[81]  X. Xian,et al.  Activation of p38 MAPK participates in brain ischemic tolerance induced by limb ischemic preconditioning by up-regulating HSP 70 , 2010, Experimental Neurology.

[82]  Zhuo Yang,et al.  Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage‐dependent sodium channels in hippocampal CA1 pyramidal neurons , 2010, Phytotherapy research : PTR.

[83]  S. Cook,et al.  Tumour cell survival signalling by the ERK1/2 pathway , 2009, Cell Death and Differentiation.

[84]  K. Plate,et al.  Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.

[85]  Mary P. Stenzel-Poore,et al.  Mechanisms of ischemic brain damage , 2008, Neuropharmacology.

[86]  J. Caprioli,et al.  Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress. , 2008, Investigative ophthalmology & visual science.

[87]  R. Medzhitov Origin and physiological roles of inflammation , 2008, Nature.

[88]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[89]  A. A. Mongin Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm. , 2007, Pathophysiology : the official journal of the International Society for Pathophysiology.

[90]  R. M. Adibhatla,et al.  Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. , 2006, Free radical biology & medicine.

[91]  A. Ascensão,et al.  Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. , 2005, Journal of applied physiology.

[92]  S. Wolffram,et al.  Tissue distribution of quercetin in rats and pigs. , 2005, The Journal of nutrition.

[93]  Z. Zuo,et al.  Pharmacokinetics and Modeling of Quercetin and Metabolites , 2005, Pharmaceutical Research.

[94]  V. Gribkoff,et al.  Voltage-gated cation channel modulators for the treatment of stroke , 2005, Expert opinion on investigational drugs.

[95]  J. Kleinjans,et al.  Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. , 2005, Mutation research.

[96]  G. Gill,et al.  SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? , 2004, Genes & development.

[97]  D. Begley,et al.  Flavonoid permeability across an in situ model of the blood-brain barrier. , 2004, Free radical biology & medicine.

[98]  Robin A. J. Smith,et al.  Delivery of bioactive molecules to mitochondria in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. Terao,et al.  Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. , 2002, Journal of agricultural and food chemistry.

[100]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  T. Sanders,et al.  Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. , 2001, The American journal of clinical nutrition.

[102]  Junying Yuan,et al.  Cross-Talk between Two Cysteine Protease Families , 2000, The Journal of cell biology.

[103]  D. Kim,et al.  Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities. , 1999, Biological & pharmaceutical bulletin.

[104]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[105]  K. Kogure,et al.  Inhibition of ischaemic tolerance in the gerbil hippocampus by quercetin and anti-heat shock protein-70 antibody. , 1993, Neuroreport.

[106]  David L. Strayer,et al.  Cognitive Function at High Altitude , 1993, Human factors.

[107]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[108]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[109]  G. Davies-Jones,et al.  Cerebrospinal fluid enolase in stroke. , 1984, Journal of neurology, neurosurgery, and psychiatry.